Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort

BACKGROUND: Although growth advantage of certain clones would ultimately translate into a clinically visible disease progression, radiological imaging does not reflect clonal evolution at molecular level. Circulating tumor DNA (ctDNA), validated as a tool for mutation detection in lung cancer, could...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yong, Hu, Chengping, Xie, Zhanhong, Wu, Lin, Zhu, Zhengfei, Rao, Chuangzhou, Liu, Li, Chen, Yuan, Liang, Naixin, Chen, Jun, Hu, Chunhong, Yang, Nong, Hu, Jie, Zhao, Weixin, Tong, Gangling, Dong, Xiaorong, Zheng, Di, Jin, Meiling, Chen, Jianhua, Huang, Meijuan, He, Yong, Rosell, Rafael, Lippi, Giuseppe, Mino-Kenudson, Mari, Han-Zhang, Han, Mao, Xinru, Zhang, Lu, Liu, Hao, Field, John K., Chuai, Shannon, Ye, Junyi, Han, Yusheng, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225135/
https://www.ncbi.nlm.nih.gov/pubmed/32420066
http://dx.doi.org/10.21037/tlcr.2020.03.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225135/
https://www.ncbi.nlm.nih.gov/pubmed/32420066
http://dx.doi.org/10.21037/tlcr.2020.03.17

Ejemplares similares